Cohance Lifesciences Limited
COHANCE
주식 순위
#6361
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
주가
$5.06
마지막 동기화: 2026-10-19
시가총액
$1.93B
변동 (1일)
-1.34%
변동 (1년)
-57.33%
국가
IN
거래 Cohance Lifesciences Limited (COHANCE)
카테고리
Healthcare
Cohance Lifesciences Limited (COHANCE)의 EPS
June 2025 기준 EPS TTM: $0.11
Cohance Lifesciences Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $0.11입니다. 2024년 말에는 회사의 EPS가 $0.14였으며, 이는 2023년의 EPS $0.20와 감소입니다.
Cohance Lifesciences Limited의 EPS 기록 (2019 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
